Circulomics Awarded $1.5M Phase II SBIR to Develop Multiplex microRNA Assay
May 13, 2015 09:17 ET
|
Circulomics
BALTIMORE, MD--(Marketwired - May 13, 2015) - Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) - National...
DiamiR Announces Presentation at Extracellular Biomarkers Summit 2015
March 11, 2015 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 11, 2015) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
November 17, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
November 03, 2014 08:02 ET
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...
DiamiR Announces Oral Presentation at the 2014 Alzheimer's Association International Conference
July 10, 2014 08:02 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 10, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
DiamiR Announces Presentation at the 2014 BIO International Convention
June 18, 2014 08:00 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - June 18, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University
May 28, 2014 05:00 ET
|
Provista Diagnostics, Inc.
NEW YORK, NY, May 28, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
Circulomics Awarded Phase I SBIR to Develop Nanobind DNA Extraction Technology
April 30, 2014 10:12 ET
|
Circulomics
BALTIMORE, MD--(Marketwired - April 30, 2014) -
Circulomics Inc has been awarded a Phase I Small Business Innovative Research (SBIR) grant by the National...
DiamiR Announces Poster Presentation on Detection and Differentiation of Neurodegenerative Diseases at the Biomarkers & Diagnostics World Congress 2014
April 28, 2014 08:00 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - April 28, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...
Diaceutics to Host Personalized Medicine (PM) Webinar: Moving Beyond Oncology - Integrating Personalized Medicine Learnings Across the Organization
March 18, 2014 09:43 ET
|
Diaceutics
NEW YORK, NY--(Marketwired - Mar 18, 2014) - Diaceutics Ltd., a leading international consulting, software and services solutions company, which helps the pharmaceutical and diagnostic...